NOVEL DIAZABICYCLIC ARYL DERIVATIVES AS CHOLINERGY LIGANDS
    1.
    发明授权
    NOVEL DIAZABICYCLIC ARYL DERIVATIVES AS CHOLINERGY LIGANDS 有权
    新型二氮杂双环芳基衍生物作为配位体的胆碱能

    公开(公告)号:EP1819709B1

    公开(公告)日:2009-02-11

    申请号:EP05817438.4

    申请日:2005-11-29

    申请人: NEUROSEARCH A/S

    CPC分类号: C07D487/08

    摘要: This invention relates to novel diazabicyclic aryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

    NOVEL DIAZABICYCLIC ARYL DERIVATIVES AS CHOLINERGY LIGANDS
    2.
    发明公开
    NOVEL DIAZABICYCLIC ARYL DERIVATIVES AS CHOLINERGY LIGANDS 有权
    新型二氮杂双环芳基衍生物作为配位体的胆碱能

    公开(公告)号:EP1819709A1

    公开(公告)日:2007-08-22

    申请号:EP05817438.4

    申请日:2005-11-29

    申请人: NEUROSEARCH A/S

    CPC分类号: C07D487/08

    摘要: This invention relates to novel diazabicyclic aryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.